Skip to main content

Via collaboration with the Cardiometabolic Disease Group, we continue to investigate new mechanisms of colchicine action in ACS patients. This work has resulted thus far in one presentation at the CSANZ annual meeting.

HRI breakthrough drug for coronavirus

Read full article